{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:44:40Z","timestamp":1790372680188,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100022547","name":"Council for European Studies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022547","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.eplepsyres.2025.107686","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:12:18Z","timestamp":1760731938000},"page":"107686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Altered synaptic functions in a humanized mouse model of down syndrome (TcMAC21): Implications for seizure susceptibility"],"prefix":"10.1016","volume":"218","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0624-7122","authenticated-orcid":false,"given":"Li-Rong","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl E.","family":"Stafstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2025.107686_bib1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1086\/520000","article-title":"Classification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypes","volume":"81","author":"Ait Yahya-Graison","year":"2007","journal-title":"Am. J. Hum. Genet"},{"key":"10.1016\/j.eplepsyres.2025.107686_bib2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nrg1448","article-title":"Chromosome 21 and Down syndrome: from genomics to pathophysiology","volume":"5","author":"Antonarakis","year":"2004","journal-title":"Nat. Rev. Genet"},{"key":"10.1016\/j.eplepsyres.2025.107686_bib3","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.031013","article-title":"Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1\/Yey mouse models of Down syndrome","author":"Aziz","year":"2018","journal-title":"Dis. Model Mech. 11"},{"key":"10.1016\/j.eplepsyres.2025.107686_bib4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1515\/revneuro-2022-0067","article-title":"Brain circuit pathology in Down syndrome: from neurons to neural networks","volume":"34","author":"Bartesaghi","year":"2023","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib5","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1152\/jn.00626.2006","article-title":"Ts65Dn, a mouse model of Down syndrome, exhibits increased GABAB-induced potassium current","volume":"97","author":"Best","year":"2007","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.expneurol.2011.11.033","article-title":"Dysfunctional hippocampal inhibition in the Ts65Dn mouse model of Down syndrome","volume":"233","author":"Best","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib7","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1152\/jn.00524.2012","article-title":"Somatic and dendritic GABA(B) receptors regulate neuronal excitability via different mechanisms","volume":"108","author":"Breton","year":"2012","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib8","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nn.2600","article-title":"Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome","volume":"13","author":"Chakrabarti","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib9","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1038\/ncomms5246","article-title":"Activity-dependent facilitation of synaptojanin and synaptic vesicle recycling by the minibrain kinase","volume":"5","author":"Chen","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib10","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neuroscience.2025.09.016","article-title":"Increased seizure susceptibility and neocortical excitability in TcMAC21 Down syndrome mice","volume":"585","author":"Chinnasamy","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.eplepsyres.2025.107686_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136288","article-title":"Mini-review: synaptojanin 1 and its implications in membrane trafficking","volume":"765","author":"Choudhry","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib12","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1093\/hmg\/dds142","article-title":"Trisomy for synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes","volume":"21","author":"Cossec","year":"2012","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.eplepsyres.2025.107686_bib13","article-title":"Infantile spasms in children with Down syndrome: identification and treatment response","volume":"6","author":"Daniels","year":"2019","journal-title":"Glob. Pedia Health"},{"key":"10.1016\/j.eplepsyres.2025.107686_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108696","article-title":"Metabotropic actions of kainate receptors modulating glutamate release","volume":"197","author":"Falcon-Moya","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.eplepsyres.2025.107686_bib15","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/jnc.15481","article-title":"Kainate receptor modulation of glutamatergic synaptic transmission in the CA2 region of the hippocampus","volume":"158","author":"Falcon-Moya","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1034\/j.1601-183X.2003.00024.x","article-title":"Understanding mental retardation in down's syndrome using trisomy 16 mouse models","volume":"2","author":"Galdzicki","year":"2003","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s11689-022-09418-0","article-title":"And clematis study G. A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABA(A)-alpha5 NAM (basmisanil) on intellectual disability associated with Down syndrome","volume":"14","author":"Goeldner","year":"2022","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.biopsych.2023.02.012","article-title":"The impact of Mmu17 Non-Hsa21 orthologous genes in the Ts65Dn mouse model of Down syndrome: the gold standard refuted","volume":"94","author":"Guedj","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2025.107686_bib19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10571-006-9066-4","article-title":"Elevated expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in cerebellar unipolar brush cells of a Down syndrome mouse model","volume":"26","author":"Harashima","year":"2006","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib20","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/cne.20844","article-title":"Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: a model of Down syndrome","volume":"494","author":"Harashima","year":"2006","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tins.2011.11.001","article-title":"Trisomy 21 and early brain development","volume":"35","author":"Haydar","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2174\/1567205020666221202102832","article-title":"Triplication of synaptojanin 1 in alzheimer's disease pathology in Down syndrome","volume":"19","author":"Hwang","year":"2022","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.eplepsyres.2025.107686_bib23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/epi4.12412","article-title":"Epileptic spasms in individuals with Down syndrome: a review of the current literature","volume":"5","author":"Kats","year":"2020","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.eplepsyres.2025.107686_bib24","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56223","article-title":"A non-mosaic transchromosomic mouse model of Down syndrome carrying the long arm of human chromosome 21","volume":"9","author":"Kazuki","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.eplepsyres.2025.107686_bib25","doi-asserted-by":"crossref","first-page":"17143","DOI":"10.1073\/pnas.222657399","article-title":"Delayed reentry of recycling vesicles into the fusion-competent synaptic vesicle pool in synaptojanin 1 knockout mice","volume":"99","author":"Kim","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.eplepsyres.2025.107686_bib26","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.nbd.2011.10.009","article-title":"Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome","volume":"45","author":"Kleschevnikov","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108379","article-title":"Neocortical neuronal production and maturation defects in the TcMAC21 mouse model of Down syndrome","volume":"26","author":"Kurabayashi","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.eplepsyres.2025.107686_bib28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ana.25935","article-title":"Neocortical slow oscillations implicated in the generation of epileptic spasms","volume":"89","author":"Lee","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib29","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nrn1118","article-title":"Roles and rules of kainate receptors in synaptic transmission","volume":"4","author":"Lerma","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002078","article-title":"DSCAM gene triplication causes excessive GABAergic synapses in the neocortex in Down syndrome mouse models","volume":"21","author":"Liu","year":"2023","journal-title":"PLoS Biol."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib31","doi-asserted-by":"crossref","first-page":"9101","DOI":"10.1523\/JNEUROSCI.21-23-09101.2001","article-title":"Synaptojanin 1 contributes to maintaining the stability of GABAergic transmission in primary cultures of cortical neurons","volume":"21","author":"Luthi","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib32","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.neuron.2007.10.032","article-title":"The dual phosphatase activity of synaptojanin1 is required for both efficient synaptic vesicle endocytosis and reavailability at nerve terminals","volume":"56","author":"Mani","year":"2007","journal-title":"Neuron"},{"issue":"Pt 2","key":"10.1016\/j.eplepsyres.2025.107686_bib33","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neubiorev.2013.12.008","article-title":"Treating enhanced GABAergic inhibition in Down syndrome: use of GABA alpha5-selective inverse agonists","volume":"46","author":"Martinez-Cue","year":"2014","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib34","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1016\/j.celrep.2018.05.011","article-title":"Excess synaptojanin 1 contributes to place cell dysfunction and memory deficits in the aging hippocampus in three types of alzheimer's disease","volume":"23","author":"Miranda","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib35","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1111\/febs.16081","article-title":"Kainate receptors: from synaptic activity to disease","volume":"289","author":"Negrete-Diaz","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1054-3589(10)58006-2","article-title":"GABAB receptor coupling to G-proteins and ion channels","volume":"58","author":"Padgett","year":"2010","journal-title":"Adv. Pharm."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib37","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1111\/j.1528-1167.2010.02657.x","article-title":"Infantile spasms: a U.S. Consensus report","volume":"51","author":"Pellock","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107686_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/18715273113126660185","article-title":"Reducing GABAergic inhibition restores cognitive functions in a mouse model of Down syndrome","volume":"13","author":"Potier","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.eplepsyres.2025.107686_bib39","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1113\/JP279645","article-title":"Kainate receptor regulation of synaptic inhibition in the hippocampus","volume":"599","author":"Pressey","year":"2021","journal-title":"J. Physiol."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib40","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31543","article-title":"Alterations of in vivo CA1 network activity in Dp(16)1Yey Down syndrome model mice","volume":"7","author":"Raveau","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.eplepsyres.2025.107686_bib41","article-title":"Pediatric epilepsy mechanisms: expanding the paradigm of Excitation\/Inhibition imbalance","volume":"6","author":"Shao","year":"2019","journal-title":"Child. (Basel)"},{"key":"10.1016\/j.eplepsyres.2025.107686_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106198","article-title":"Increased propensity for infantile spasms and altered neocortical excitation-inhibition balance in a mouse model of Down syndrome carrying human chromosome 21","volume":"184","author":"Shao","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib43","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1528-1157.1996.tb00535.x","article-title":"Early clinical and EEG features of infantile spasms in Down syndrome","volume":"37","author":"Silva","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107686_bib44","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1469-8749.1994.tb11894.x","article-title":"Infantile spasms in children with Down syndrome","volume":"36","author":"Stafstrom","year":"1994","journal-title":"Dev. Med Child Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib45","article-title":"Infantile spasms in pediatric Down syndrome: potential mechanisms driving therapeutic considerations","volume":"11","author":"Stafstrom","year":"2024","journal-title":"Child. (Basel)"},{"key":"10.1016\/j.eplepsyres.2025.107686_bib46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1469-8749.1991.tb05108.x","article-title":"Seizures in children with Down syndrome: etiology, characteristics and outcome","volume":"33","author":"Stafstrom","year":"1991","journal-title":"Dev. Med Child Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib47","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib48","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1038\/s41467-019-13004-9","article-title":"Unbalanced dendritic inhibition of CA1 neurons drives spatial-memory deficits in the Ts2Cje Down syndrome model","volume":"10","author":"Valbuena","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.eplepsyres.2025.107686_bib49","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0896-6273(03)00644-5","article-title":"Synaptojanin is recruited by endophilin to promote synaptic vesicle uncoating","volume":"40","author":"Verstreken","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.eplepsyres.2025.107686_bib50","doi-asserted-by":"crossref","first-page":"9415","DOI":"10.1073\/pnas.0803756105","article-title":"Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of down's syndrome","volume":"105","author":"Voronov","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.eplepsyres.2025.107686_bib51","doi-asserted-by":"crossref","first-page":"e1465","DOI":"10.1542\/peds.2006-3448","article-title":"Fetal Down syndrome brains exhibit aberrant levels of neurotransmitters critical for normal brain development","volume":"120","author":"Whittle","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.eplepsyres.2025.107686_bib52","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/s41380-022-01454-5","article-title":"APP and DYRK1A regulate axonal and synaptic vesicle protein networks and mediate alzheimer's pathology in trisomy 21 neurons","volume":"27","author":"Wu","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2025.107686_bib53","article-title":"Altered intrinsic and network properties of neocortical neurons in the Ts65Dn mouse model of Down syndrome","volume":"3","author":"Xu","year":"2015","journal-title":"Physiol. Rep."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121125001871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121125001871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T20:43:04Z","timestamp":1764016984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121125001871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":53,"alternative-id":["S0920121125001871"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107686","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered synaptic functions in a humanized mouse model of down syndrome (TcMAC21): Implications for seizure susceptibility","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107686","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107686"}}